Novugen Uzbekistan

Novugen is a global multi-national pharmaceutical company with a focus on making medicine affordable and accessible to all. Head-quartered in Malaysia, Novugen is focussing on developing high-quality medicines by following guidelines of stringent regulatory authorities including USFDA (USA) and EMA (Europe). It is the first company from the ASEAN region to have filed a pharma product for registration in USA and registered 4 DMF in USA for its API. It’s state-of- the art global R&D centre, spreading over 40,000 sq.ft, has a team of over 200 scientists working on most complex generic formulations to cater to the unmet needs of patients worldwide.

As a part of its long-term vision Novugen has established its presence in the CIS region by establishing a state-of-the-art manufacturing facility in Uzbekistan. Novugen Uzbekistan will be launching over 25 products in the year 2020 catering to all major therapeutic areas and indications from its existing global portfolio. These products were developed in the Global R&D center in Malaysia and are being successfully launched globally.

Novugen Uzbekistan aspires to change the healthcare landscape of Uzbekistan by locally manufacturing high quality, affordable medicines and catering to the unmet needs of Uzbek population.

THE GROUP: Novugen Pharma is part of a UAE based group with more than 25 years of experience in strategic healthcare businesses and development of world class healthcare facilities around the globe. The group has made investments in pharmaceutical companies globally, including Getz Pharma and Oncogen Pharma and is operational in over 40 countries.